| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | GSK716155 | |
| 3 | Generic Name | ||
| 4 | Mechanism | albumin-fused GLP1 | |
| 5 | Clinical Trials | ||
| 6 | Phase I PK/PD - Began 10/2006 | ||
| 7 | n=80 healthy or diabetes | ||
| 8 | Looking at different injection sites. Could mean first phase 1 had a problem. | ||
| 9 | |||
| 10 | Phase I - Began 2/2006 | ||
| 11 | 7 days of dosing |